68 related articles for article (PubMed ID: 25667475)
1. VEGFR3 and CD31 as prognostic factors in renal cell cancer.
Virman J; Bono P; Luukkaala T; Sunela K; Kujala P; Kellokumpu-Lehtinen PL
Anticancer Res; 2015 Feb; 35(2):921-7. PubMed ID: 25667475
[TBL] [Abstract][Full Text] [Related]
2. Combined Angiogenesis and Proliferation Markers' Expressions as Long-Term Prognostic Factors in Renal Cell Cancer.
Virman JP; Bono P; Luukkaala TH; Sunela KL; Kujala PM; Kellokumpu-Lehtinen PL
Clin Genitourin Cancer; 2016 Aug; 14(4):e283-9. PubMed ID: 26821530
[TBL] [Abstract][Full Text] [Related]
3. Novel Angiogenesis Markers as Long-Term Prognostic Factors in Patients With Renal Cell Cancer.
Lampinen AM; Virman JP; Bono P; Luukkaala TH; Sunela KL; Kujala PM; Saharinen P; Kellokumpu-Lehtinen PI
Clin Genitourin Cancer; 2017 Feb; 15(1):e15-e24. PubMed ID: 27554585
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
Dubinski W; Gabril M; Iakovlev VV; Scorilas A; Youssef YM; Faragalla H; Kovacs K; Rotondo F; Metias S; Arsanious A; Plotkin A; Girgis AH; Streutker CJ; Yousef GM
Hum Pathol; 2012 Jul; 43(7):1037-43. PubMed ID: 22204709
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma.
Yilmazer D; Han U; Onal B
Int Urol Nephrol; 2007; 39(3):691-8. PubMed ID: 17180739
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
7. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
[TBL] [Abstract][Full Text] [Related]
8. Expression of VEGFR3 in glioma endothelium correlates with tumor grade.
Grau SJ; Trillsch F; Herms J; Thon N; Nelson PJ; Tonn JC; Goldbrunner R
J Neurooncol; 2007 Apr; 82(2):141-50. PubMed ID: 17115285
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.
Papworth K; Bergh A; Grankvist K; Ljungberg B; Sandlund J; Rasmuson T
Acta Oncol; 2013 Jan; 52(1):159-65. PubMed ID: 22731830
[TBL] [Abstract][Full Text] [Related]
10. Receptors for advanced glycation end products (RAGE) is associated with microvessel density and is a prognostic biomarker for clear cell renal cell carcinoma.
Guo Y; Xia P; Zheng JJ; Sun XB; Pan XD; Zhang X; Wu CZ
Biomed Pharmacother; 2015 Jul; 73():147-53. PubMed ID: 26211596
[TBL] [Abstract][Full Text] [Related]
11. Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib.
Terakawa T; Miyake H; Kusuda Y; Fujisawa M
Urol Oncol; 2013 May; 31(4):493-8. PubMed ID: 21478036
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
15. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
[TBL] [Abstract][Full Text] [Related]
16. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.
Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G
Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
18. [Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].
Zhang YH; Diao L; Yang Q; Duo J; Liu YX; Liu SX; Yao X
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):752-6. PubMed ID: 21163065
[TBL] [Abstract][Full Text] [Related]
19. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis.
García-Tello A; Angulo JC; Andrés G; Ramón de Fata F; Sánchez-Chapado M; López JI
Actas Urol Esp; 2014 Oct; 38(8):506-14. PubMed ID: 24702909
[TBL] [Abstract][Full Text] [Related]
20. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
